Skip to content

Funding
Launch
Partnership
Acquisition
Policy
Exit & IPO

iFAST Diagnostics

UK Biotech iFAST Diagnostics Secures £5M Series B to Accelerate Infection Testing Innovation

May 27, 2026 by James O'Brien

UK biotech iFAST Diagnostics raises £5M to speed up infection testing and tackle antimicrobial resistance

Categories Funding Tags €5M–€20M, Healthtech, iFAST Diagnostics, Series B, United Kingdom Leave a comment

Browse by Country

Latest

Polish Food Delivery Platform Pyszne.pl to Exit Courier Business, Shift to Third-Party LogisticsJul 20, 2026

Hamburg Startup toern Pivots to AI-Powered Returns Management for E-CommerceJul 20, 2026

Monterro Acquires Finnish Fintech MORS Software to Bolster Banking Compliance SolutionsJul 20, 2026

Cambridge AI Startup CuspAI Secures $450 Million Series B to Accelerate Materials DiscoveryJul 20, 2026

Dutch Audio Ad Platform adpaq Enables AI Agents to Autonomously Manage Campaigns via New MCP ServerJul 20, 2026

EU Markets

Defence Funds, AI Warnings, and a €30B Bank Battle: What Europe's Financial Markets Mean for Your Startup This WeekJul 17, 2026

Digital Euros, Defense Billions, and AI Pivots: What Europe's Financial Markets Mean for Your Startup This WeekJul 10, 2026

Techstars Startup Weekend to Put the Isle of Man on the Global Startup MapJul 5, 2026

Europe's Startup Ecosystem Navigates Defense Boom, AI Debate, and Crypto's Institutional MomentJul 3, 2026

EU Startups News

• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.